Avanza Fonder’s Regeneron Pharmaceuticals REGN Stock Holding History

Avanza Fonder’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.18M	Buy	11,517 +183	+2%	+$125K	0.16%	120
2026 Q1	$8.76M	Sell	11,334 -853	-7%	-$653K	0.24%	85
2025 Q4	$9.41M	Buy	12,187 +1,590	+15%	+$1.08M	0.24%	79
2025 Q3	$5.96M	Buy	10,597 +860	+9%	+$486K	0.15%	115
2025 Q2	$5.11M	Buy	9,737 +838	+9%	+$468K	0.15%	119
2025 Q1	$5.57M	Sell	8,899 -1,509	-14%	-$1.04M	0.18%	105
2024 Q4	$7.41M	Buy	+10,408	New	+$8.73M	0.22%	81

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MCI

McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Avanza Fonder's REGN Position: Q2 2026 in Review

Avanza Fonder increased its Regeneron Pharmaceuticals (REGN) stake by 1.6% in Q2 2026, buying an estimated $125K and bringing the position to 11,517 shares worth $7.18M. The position accounts for 0.16% of the portfolio, ranked #120.

Avanza Fonder first reported a position in REGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.41M in Q4 2025. 459 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Avanza Fonder held 11,517 shares of Regeneron Pharmaceuticals worth $7.18M as of Q2 2026.
Avanza Fonder bought 183 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $125K.
Regeneron Pharmaceuticals made up 0.16% of Avanza Fonder's portfolio in Q2 2026, its #120 holding.
Avanza Fonder first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
Avanza Fonder's Regeneron Pharmaceuticals position peaked at $9.41M in Q4 2025.
459 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Avanza Fonder's 13F filing for Q2 2026, filed 17 Jul 2026.